InsiderClue
Insiders · Profile

BRYNJELSEN SEAN

President & CEO at Eton Pharmaceuticals. Filing since 15 Nov 2018. CIK 0001669976

Company
Date
Role
Action
Shares
Amount
Of holding
ETON Eton Pharmaceuticals, Inc.
20 Aug 2026
President & CEO
Sold at will
91,022
$5.53M
8.7%
ETON Eton Pharmaceuticals, Inc.
19 Aug 2026
President & CEO
Sold at will
8,978
$562.47K
0.8%
ETON Eton Pharmaceuticals, Inc.
28 May 2026
President & CEO
Sold at will
120,000
$3.83M
12.6%
ETON Eton Pharmaceuticals, Inc.
5 Jun 2025
President & CEO
Sold at will
70,000
$1.18M
2.4%
ETON Eton Pharmaceuticals, Inc.
4 Jun 2025
President & CEO
Sold at will
70,000
$1.19M
2.3%
ETON Eton Pharmaceuticals, Inc.
3 Jun 2025
President & CEO
Sold at will
70,000
$1.23M
2.3%
ETON Eton Pharmaceuticals, Inc.
22 Sep 2022
Chief Executive Officer
Bought
10,000
$21.04K
1.0%
ETON Eton Pharmaceuticals, Inc.
20 Aug 2021
President & CEO
Bought
10,000
$43.20K
1.0%
ETON Eton Pharmaceuticals, Inc.
3 Jun 2021
President & CEO
Bought
5,000
$29.80K
0.5%
ETON Eton Pharmaceuticals, Inc.
13 Aug 2019
President & CEO
Bought
5,000
$30.75K
0.5%
ETON Eton Pharmaceuticals, Inc.
21 May 2019
President & CEO
Bought
8,600
$68.43K
0.9%
ETON Eton Pharmaceuticals, Inc.
20 May 2019
President & CEO
Bought
1,400
$10.89K
0.1%
ETON Eton Pharmaceuticals, Inc.
15 Nov 2018
President & CEO
Bought
10,000
$60.00K
1.0%
13 decisions on file.